CONTROLLED TRIAL OF BROMOCRIPTINE, QUINŒSTROL, AND PLACEBO IN SUPPRESSION OF PUERPERAL LACTATION
| Autor: | Sheila M. Walker, BryanM. Hibbard, RobertHarvard Davis, Keith Griffiths, G.V. Groom |
|---|---|
| Rok vydání: | 1975 |
| Předmět: |
Time Factors
Breast pain Placebo law.invention Placebos Randomized controlled trial Pregnancy law Lactation Quinestrol medicine Humans Milk flow Ergolines Bromocriptine Clinical Trials as Topic Milk Human business.industry General Medicine Plasma prolactin Prolactin medicine.anatomical_structure Norpregnatrienes Anesthesia Drug Evaluation Female medicine.symptom business medicine.drug |
| Zdroj: | The Lancet. 306:842-845 |
| ISSN: | 0140-6736 |
| DOI: | 10.1016/s0140-6736(75)90235-4 |
| Popis: | 2-bromo-α-ergocryptine (bromocriptine) in a dosage of 2·5 mg twice daily caused a rapid fall in plasma prolactin. It was more effective than either a single dose of 4 mg quinœstrol or a placebo in suppressing puerperal lactation, as judged by milk flow and the relief of breast pain and congestion. Patients who received quinœstrol were more comfortable than those who received placebo. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|